Brief: Sellas Life Sciences Secures $23.6 Million in Gross Proceeds Through Institutional Warrant Exercise
11/09/2025 13:59
Sept 11 (Reuters) - Sellas Life Sciences Group Inc SLS.O: SELLAS LIFE SCIENCES GROUP ANNOUNCES EXERCISE OF EXISTING WARRANTS HELD BY A CURRENT INSTITUTIONAL INVESTOR FOR $23.6 MILLION IN GROSS PROCEEDS Source text: ID:nGNXFJ2wh Further company coverage: SLS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses